Merck Serono | Sales by region
As a result of the Serono acquisition, sales of the Merck Serono division rose in Europe by 93% to €2,441 million in 2007. In comparison with pro forma sales for 2006, growth was 8.4%. High growth rates were achieved in Spain, Italy and Belgium – also on a pro forma basis. The largest markets were France with sales of €580 million, followed by Germany with €476 million, Italy with €269 million and Spain with €268 million. With sales of €730 million, the new division also has a strong presence in North America due to the acquisition of Serono. Business in Latin America was characterized by growth. Thanks to the acquisition, Merck Serono captured new markets there and posted a 56% increase in sales to €492 million. Pro forma growth was 16%. The division was particularly successful in Brazil, and also generated robust growth in Venezuela and Colombia. Sales in the region Asia, Africa and Australasia rose by 74% as a result of the acquisition. Merck Serono expanded its presence in Japan but remained weak overall.
